Skip to main content
. 2018 May 23;14:150–157. doi: 10.1016/j.molmet.2018.05.014

Table 1.

Baseline characteristics and GIP measurements.

Parameter All patients PAD
(no)
PAD
(yes)
No CAD PAD
(no)
PAD
(no)
Stable CAD PAD
(no)
PAD
(yes)
n 731 634 97 257 242 15 474 392 82
Age 65.3 ± 13.2a 64.5 ± 13.4 70.3 ± 10.2 60.6 ± 15.8 60.3 ± 15.8 65.8 ± 15.7 67.9 ± 10.7 67.2 ± 11.0 71.2 ± 8.8
BMI 28.3 ± 5.6b 28.3 ± 5.7 28.2 ± 4.9 28.6 ± 7.1 28.6 ± 7.2 27.8 ± 4.6 28.2 ± 4.6 28.2 ± 4.6 28.3 ± 5.0
Sex (male) 542 (74.3%)c 466 (73.7%) 76 (78.4%) 154 (60.4%) 146 (60.8%) 8 (53.3%) 388 (81.9%) 320 (81.6%) 68 (82.9%)
Hypertension 527 (72.2%)a 447 (70.5%) 80 (83.3%) 145 (56.6%) 137 (56.6%) 8 (57.1%) 382 (80.6%) 382 (80.6%) 72 (87.8%)
DM 239 (32.7%) 199 (31.4%) 40 (41.2%) 63 (24.5%) 61 (25.2%) 2 (13.3%) 176 (37.1%) 138 (35.2%) 38 (46.3%)
CRP 10.5 ± 16.7d 10.5 ± 17.4 10.1 ± 11.9 11.0 ± 16.9 11.0 ± 17.2 10.2 ± 10.4 10.2 ± 16.6 10.2 ± 17.5 10.0 ± 12.3
WBC 7.4 ± 2.5e 7.4 ± 2.5 7.2 ± 2.4 6.9 ± 2.1 7.0 ± 2.1 6.1 ± 1.5 7.6 ± 2.6 7.6 ± 2.7 7.4 ± 2.4
Smoker 289 (39.6%)a 235 (37.1%) 54 (56.3%) 89 (34.6%) 78 (32.2%) 11 (73.3%) 200 (42.3%) 157 (40.1%) 43 (53.1%)
GIP level 343.5 ± 296.7 (272.0, 73.1-545.6)f 332.7 ± 292.5 (258.4, 71.2-533.9)1 413.0 ± 315.3 (376.2, 118.2-624.5)1 370.7 ± 314.9 (310.8, 73.5-567.4)2 360.5 ± 310.4 (292.1, 71.0-551.0)3 531.6 ± 352.1 (475.0, 230.5-1008.2)3 328.9 ± 285.8 (252.9, 72.6-533.3)2 315.7 ± 280.1 (241.1, 71.2-519.5)4 391.2 ± 305.5 (368.1, 95.4-615.5)4

Continuous variables are expressed as mean ± SD and (median, Q1 – Q3) in case of skewed data. Categorical variables are shown as absolute and relative frequencies. a 1 missing value, b 12 missing values, c 2 missing values, d 118 missing values, e 92 missing values, f 11 missing values. 1 PAD vs. No PAD p-value = 0.0165, 2 CAD vs. No CAD pvalue= 0.1869, 3 No CAD: PAD vs. No PAD p-value = 0.0632, 4 Stable CAD: PAD vs. No PAD p-value = 0.0389.